IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MERONI, MARICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.317
NA - Nord America 3.856
EU - Europa 2.958
SA - Sud America 332
AF - Africa 102
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 11.609
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.711
CN - Cina 1.464
SG - Singapore 1.045
GB - Regno Unito 741
IT - Italia 624
DE - Germania 367
HK - Hong Kong 367
VN - Vietnam 334
BR - Brasile 261
RU - Federazione Russa 221
SE - Svezia 218
BD - Bangladesh 191
KR - Corea 187
IN - India 184
FR - Francia 161
JP - Giappone 134
FI - Finlandia 117
IE - Irlanda 105
NL - Olanda 102
CA - Canada 83
ID - Indonesia 72
DK - Danimarca 65
IR - Iran 63
TW - Taiwan 57
TR - Turchia 50
AU - Australia 41
ES - Italia 40
BE - Belgio 38
MX - Messico 35
ZA - Sudafrica 28
PL - Polonia 27
AR - Argentina 26
AT - Austria 20
EG - Egitto 20
CI - Costa d'Avorio 19
CH - Svizzera 18
IL - Israele 18
MO - Macao, regione amministrativa speciale della Cina 18
IQ - Iraq 16
PH - Filippine 16
RO - Romania 16
PK - Pakistan 15
GR - Grecia 13
UA - Ucraina 13
CO - Colombia 12
UZ - Uzbekistan 12
CL - Cile 11
KE - Kenya 10
MY - Malesia 10
EC - Ecuador 8
HU - Ungheria 8
TH - Thailandia 8
AE - Emirati Arabi Uniti 7
RS - Serbia 7
CR - Costa Rica 6
JM - Giamaica 6
NO - Norvegia 6
PT - Portogallo 6
JO - Giordania 5
MA - Marocco 5
PY - Paraguay 5
AZ - Azerbaigian 4
HN - Honduras 4
SA - Arabia Saudita 4
SY - Repubblica araba siriana 4
TN - Tunisia 4
AM - Armenia 3
AO - Angola 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
ET - Etiopia 3
HR - Croazia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LT - Lituania 3
LU - Lussemburgo 3
OM - Oman 3
PA - Panama 3
QA - Qatar 3
SI - Slovenia 3
UY - Uruguay 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BT - Bhutan 2
BY - Bielorussia 2
CM - Camerun 2
CV - Capo Verde 2
CY - Cipro 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
MM - Myanmar 2
NP - Nepal 2
PR - Porto Rico 2
TT - Trinidad e Tobago 2
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
Totale 11.593
Salva come PNG Salva come JPEG
Città #
Singapore 645
Southend 611
Ashburn 437
San Jose 283
Hong Kong 282
Dallas 247
Fairfield 219
Beijing 203
Milan 192
Frankfurt am Main 177
Chandler 163
Council Bluffs 139
Wilmington 123
New York 103
Dublin 100
Santa Clara 96
Los Angeles 92
Seattle 92
Houston 91
Shanghai 90
Ann Arbor 88
Hanoi 85
Cambridge 84
Helsinki 84
Woodbridge 82
Ho Chi Minh City 81
Hangzhou 79
Princeton 76
Guangzhou 70
Nanjing 65
Jakarta 64
Munich 60
The Dalles 56
Hefei 53
Lauterbourg 52
Bengaluru 50
Moscow 48
Redwood City 48
Seoul 47
Phoenix 45
Rome 44
Buffalo 43
Tokyo 40
Dearborn 38
São Paulo 35
Columbus 31
Shenyang 29
Toronto 29
Changsha 28
Chicago 28
Central 27
Taipei 26
Cangzhou 24
Des Moines 24
Tianjin 24
London 23
New Delhi 21
Chengdu 20
Nuremberg 20
Abidjan 19
Istanbul 19
Amsterdam 18
Atlanta 18
Wuhan 18
Brussels 17
Da Nang 17
Haiphong 17
Washington 17
Delhi 16
Jinan 16
Boardman 15
Fuzhou 15
Sydney 15
Chongqing 14
Dong Ket 14
Macao 14
San Diego 14
Montreal 13
Piscataway 13
Bari 12
Goyang-si 12
Naples 12
Orem 12
Silver Spring 12
Suwon 12
Tehran 12
Ankara 11
Berlin 11
Indianapolis 11
Lucknow 11
Shenzhen 11
Vienna 11
Warsaw 11
Buk-gu 10
Dhaka 10
McAllen 10
Suzhou 10
Taichung 10
Tashkent 10
Turin 10
Totale 6.806
Salva come PNG Salva come JPEG
Nome #
Recreating gut-liver axis during NAFLD onset by using a Caco-2/HepG2 co-culture system 834
The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development : a potential therapeutic target? 607
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals 438
DOWN-REGULATION OF HEPATIC MBOAT7 BY HYPERINSULINEMIA FAVORS STEATOSIS DEVELOPMENT 406
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent 385
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models 343
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease 318
MAFLD in COVID-19 patients: an insidious enemy 316
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker 313
The rs2294918 E434K variant modulates PNPLA3 expression and liver damage 306
β-Klotho gene variation is associated with liver damage in children with NAFLD 304
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 298
Genetic and metabolic factors: the perfect combination to treat metabolic associated fatty liver disease 290
PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis 286
MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD 255
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease 244
Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis 237
Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in nonalcoholic fatty liver disease 228
Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes: Mboat7 reduction and hepatic steatosis 227
Impact of natural neuromedin-B receptor variants on iron metabolism 221
Liver fat accumulation is associated with circulating PCSK9 221
Expanding the phenotypic spectrum of non-alcoholic fatty liver disease and hypertriglyceridemia 204
MiRNA signature in NAFLD: A turning point for a non-invasive diagnosis 204
Alcohol or gut microbiota : who is the guilty? 196
$\upalpha$-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study [alpha-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study] 189
Recent advances of drugs monitoring in oral fluid and comparison with blood 186
Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies 184
An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians 178
{PD}-1/{PD}-L1 Immuno-Mediated Therapy in {NAFLD}: Advantages and Obstacles in the Treatment of Advanced Disease 177
Salivary biomarkers: novel noninvasive tools to diagnose chronic inflammation 175
Circulating indian hedgehog is a marker of the hepatocyte-TAZ pathway in experimental NASH and is elevated in humans with NASH 174
Nutrition and genetics in NAFLD : The perfect binomium 168
Notch signaling and progenitor/ductular reaction in steatohepatitis 165
Neurotensin up-regulation is associated with advanced fibrosis and hepatocellular carcinoma in patients with MAFLD 164
Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease 163
Genetics is of the essence to face NAFLD 161
The rs599839 a>g variant disentangles cardiovascular risk and hepatocellular carcinoma in nafld patients 157
The α-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study 152
From Environment to Genome and Back : a Lesson from HFE Mutations 144
The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value 143
Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease 141
Mir-101-3p downregulation promotes fibrogenesis by facilitating hepatic stellate cell transdifferentiation during insulin resistance 140
The role of probiotics in nonalcoholic fatty liver disease : A new insight into therapeutic strategies 136
Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending? 136
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores 133
Notch-mediated hepatocyte MCP-1 secretion causes liver fibrosis 128
Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort" [J Hepatol (2020) 505-515] 113
Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis 109
Hepatic IRF3 fuels dysglycemia in obesity through direct regulation of Ppp2r1b 104
MAFLD definition underestimates the risk to develop HCC in genetically predisposed patients 99
Next Generation Sequencing Allows Identification of a Novel Mutation in the TfR2 Gene and Outperforms the Conventional Diagnostic Techniques 94
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically-characterised cohort 84
Exploring multiorgan mitochondrial dysfunction in the switch toward progressive MASLD in AMLN mice 61
Artificial intelligence as a ploy to delve into the intricate link between genetics and mitochondria in patients with MASLD 59
Single Cell Analysis Reveals the Presence of Novel Intermediate Cells in Both Mice and Patients With Severe MASLD 46
The KLB rs12152703 variant confers protection against hepatic inflammation in patients with MASLD by boosting Klotho-beta expression 13
null 3
Totale 11.960
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.312
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.312
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021168 0 0 0 0 0 0 0 0 0 0 90 78
2021/2022910 75 63 56 89 49 54 50 90 92 61 104 127
2022/2023990 82 83 90 77 97 169 29 86 139 22 69 47
2023/2024982 43 93 71 85 179 78 86 50 42 44 87 124
2024/20252.102 122 229 67 210 157 86 137 195 125 190 207 377
2025/20264.309 415 293 497 299 375 232 642 222 502 315 517 0
Totale 11.960